vs
ALPHA PRO TECH LTD（APT）与Sanara MedTech Inc.（SMTI）财务数据对比。点击上方公司名可切换其他公司
Sanara MedTech Inc.的季度营收约是ALPHA PRO TECH LTD的2.0倍（$27.5M vs $13.9M）。ALPHA PRO TECH LTD净利率更高（5.0% vs -5.9%，领先10.9%）。Sanara MedTech Inc.同比增速更快（4.6% vs 0.3%）。Sanara MedTech Inc.自由现金流更多（$3.9M vs $51.0K）。过去两年Sanara MedTech Inc.的营收复合增速更高（21.8% vs 1.4%）
Alpha Pro Tech Ltd是一家研发、生产和销售一次性防护服饰、口罩等个人防护用品及耐候屏障等建筑供应产品的企业，核心市场位于北美，主要服务医疗、工业、建筑领域的客户。
Sanara MedTech Inc.是一家总部位于美国的医疗科技企业，专注于研发、生产和销售外科手术、伤口护理、康复期护理类创新医疗产品，主要服务北美地区的医院、医疗机构及长期护理场所，旗下多款产品获FDA认证，旨在提升患者护理效果并降低医疗运营成本。
APT vs SMTI — 直观对比
营收规模更大
SMTI
是对方的2.0倍
$13.9M
营收增速更快
SMTI
高出4.3%
0.3%
净利率更高
APT
高出10.9%
-5.9%
自由现金流更多
SMTI
多$3.8M
$51.0K
两年增速更快
SMTI
近两年复合增速
1.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $13.9M | $27.5M |
| 净利润 | $698.0K | $-1.6M |
| 毛利率 | 37.1% | 93.2% |
| 营业利润率 | 6.9% | 23.5% |
| 净利率 | 5.0% | -5.9% |
| 营收同比 | 0.3% | 4.6% |
| 净利润同比 | -17.6% | 5.3% |
| 每股收益（稀释后） | $0.06 | $-0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APTSMTI
| Q4 25 | $13.9M | $27.5M | ||
| Q3 25 | $14.8M | $26.3M | ||
| Q2 25 | $16.7M | $25.8M | ||
| Q1 25 | $13.8M | $23.4M | ||
| Q4 24 | $13.8M | $26.3M | ||
| Q3 24 | $14.3M | $21.7M | ||
| Q2 24 | $16.3M | $20.2M | ||
| Q1 24 | $13.5M | $18.5M |
净利润APTSMTI
| Q4 25 | $698.0K | $-1.6M | ||
| Q3 25 | $976.0K | $-30.4M | ||
| Q2 25 | $1.2M | $-2.0M | ||
| Q1 25 | $613.0K | $-3.5M | ||
| Q4 24 | $847.0K | $-1.7M | ||
| Q3 24 | $862.0K | $-2.9M | ||
| Q2 24 | $1.6M | $-3.5M | ||
| Q1 24 | $576.0K | $-1.8M |
毛利率APTSMTI
| Q4 25 | 37.1% | 93.2% | ||
| Q3 25 | 39.7% | 92.9% | ||
| Q2 25 | 36.8% | 92.5% | ||
| Q1 25 | 39.0% | 92.2% | ||
| Q4 24 | 37.6% | 91.4% | ||
| Q3 24 | 38.5% | 90.8% | ||
| Q2 24 | 42.0% | 90.0% | ||
| Q1 24 | 40.2% | 89.8% |
营业利润率APTSMTI
| Q4 25 | 6.9% | 23.5% | ||
| Q3 25 | 7.4% | 11.2% | ||
| Q2 25 | 8.0% | -0.1% | ||
| Q1 25 | 3.3% | -8.9% | ||
| Q4 24 | 4.9% | 18.6% | ||
| Q3 24 | 5.2% | 3.6% | ||
| Q2 24 | 10.5% | -14.3% | ||
| Q1 24 | 2.4% | -8.3% |
净利率APTSMTI
| Q4 25 | 5.0% | -5.9% | ||
| Q3 25 | 6.6% | -115.5% | ||
| Q2 25 | 7.5% | -7.8% | ||
| Q1 25 | 4.4% | -15.1% | ||
| Q4 24 | 6.1% | -6.5% | ||
| Q3 24 | 6.0% | -13.2% | ||
| Q2 24 | 10.1% | -17.4% | ||
| Q1 24 | 4.3% | -9.5% |
每股收益（稀释后）APTSMTI
| Q4 25 | $0.06 | $-0.32 | ||
| Q3 25 | $0.09 | $-3.40 | ||
| Q2 25 | $0.12 | $-0.23 | ||
| Q1 25 | $0.06 | $-0.41 | ||
| Q4 24 | $0.07 | $-0.18 | ||
| Q3 24 | $0.08 | $-0.34 | ||
| Q2 24 | $0.15 | $-0.41 | ||
| Q1 24 | $0.05 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.0M | $16.6M |
| 总债务越低越好 | — | $46.0M |
| 股东权益账面价值 | $62.5M | $5.9M |
| 总资产 | $74.1M | $72.9M |
| 负债/权益比越低杠杆越低 | — | 7.74× |
8季度趋势，按日历期对齐
现金及短期投资APTSMTI
| Q4 25 | $17.0M | $16.6M | ||
| Q3 25 | $17.7M | $14.9M | ||
| Q2 25 | $14.5M | $17.0M | ||
| Q1 25 | $13.4M | $20.7M | ||
| Q4 24 | $18.6M | $15.9M | ||
| Q3 24 | $18.4M | $16.3M | ||
| Q2 24 | $16.2M | $6.2M | ||
| Q1 24 | $18.5M | $2.8M |
总债务APTSMTI
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $9.7M |
股东权益APTSMTI
| Q4 25 | $62.5M | $5.9M | ||
| Q3 25 | $62.5M | $6.1M | ||
| Q2 25 | $62.2M | $35.4M | ||
| Q1 25 | $61.7M | $36.7M | ||
| Q4 24 | $62.2M | $39.4M | ||
| Q3 24 | $62.1M | $39.8M | ||
| Q2 24 | $62.0M | $41.7M | ||
| Q1 24 | $61.6M | $43.3M |
总资产APTSMTI
| Q4 25 | $74.1M | $72.9M | ||
| Q3 25 | $73.9M | $71.1M | ||
| Q2 25 | $73.2M | $98.8M | ||
| Q1 25 | $72.2M | $96.4M | ||
| Q4 24 | $73.7M | $88.1M | ||
| Q3 24 | $73.3M | $88.5M | ||
| Q2 24 | $72.7M | $73.4M | ||
| Q1 24 | $72.7M | $70.9M |
负债/权益比APTSMTI
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $318.0K | $3.9M |
| 自由现金流经营现金流 - 资本支出 | $51.0K | $3.9M |
| 自由现金流率自由现金流/营收 | 0.4% | 14.0% |
| 资本支出强度资本支出/营收 | 1.9% | 0.3% |
| 现金转化率经营现金流/净利润 | 0.46× | — |
| 过去12个月自由现金流最近4个季度 | $1.7M | $2.2M |
8季度趋势，按日历期对齐
经营现金流APTSMTI
| Q4 25 | $318.0K | $3.9M | ||
| Q3 25 | $3.9M | $2.2M | ||
| Q2 25 | $2.1M | $2.7M | ||
| Q1 25 | $-4.0M | $-2.0M | ||
| Q4 24 | $2.4M | $932.0K | ||
| Q3 24 | $5.3M | $2.1M | ||
| Q2 24 | $-873.0K | $-1.4M | ||
| Q1 24 | $-1.2M | $-1.6M |
自由现金流APTSMTI
| Q4 25 | $51.0K | $3.9M | ||
| Q3 25 | $3.8M | $1.1M | ||
| Q2 25 | $1.9M | $902.7K | ||
| Q1 25 | $-4.1M | $-3.7M | ||
| Q4 24 | $970.0K | $859.9K | ||
| Q3 24 | $3.2M | $2.0M | ||
| Q2 24 | $-1.0M | $-1.5M | ||
| Q1 24 | $-1.3M | $-1.7M |
自由现金流率APTSMTI
| Q4 25 | 0.4% | 14.0% | ||
| Q3 25 | 25.9% | 4.2% | ||
| Q2 25 | 11.7% | 3.5% | ||
| Q1 25 | -29.6% | -15.9% | ||
| Q4 24 | 7.0% | 3.3% | ||
| Q3 24 | 22.3% | 9.4% | ||
| Q2 24 | -6.2% | -7.3% | ||
| Q1 24 | -9.3% | -9.0% |
资本支出强度APTSMTI
| Q4 25 | 1.9% | 0.3% | ||
| Q3 25 | 0.7% | 4.0% | ||
| Q2 25 | 0.8% | 6.8% | ||
| Q1 25 | 1.0% | 7.4% | ||
| Q4 24 | 10.4% | 0.3% | ||
| Q3 24 | 15.1% | 0.0% | ||
| Q2 24 | 0.8% | 0.3% | ||
| Q1 24 | 0.6% | 0.4% |
现金转化率APTSMTI
| Q4 25 | 0.46× | — | ||
| Q3 25 | 4.02× | — | ||
| Q2 25 | 1.68× | — | ||
| Q1 25 | -6.46× | — | ||
| Q4 24 | 2.85× | — | ||
| Q3 24 | 6.18× | — | ||
| Q2 24 | -0.53× | — | ||
| Q1 24 | -2.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APT
暂无分部数据
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
